1. Xie, Yongjie, Liu, Yang, Ding, Jinsheng, Hu, Xin, Wu, Liangliang. 2022. Identification of DDX31 as a Potential Oncogene of Invasive Metastasis and Proliferation in PDAC. In Frontiers in cell and developmental biology, 10, 762372. doi:10.3389/fcell.2022.762372. https://pubmed.ncbi.nlm.nih.gov/35237592/
2. Fukawa, Tomoya, Ono, Masaya, Matsuo, Taisuke, Kanayama, Hiro-omi, Katagiri, Toyomasa. 2012. DDX31 regulates the p53-HDM2 pathway and rRNA gene transcription through its interaction with NPM1 in renal cell carcinomas. In Cancer research, 72, 5867-77. doi:10.1158/0008-5472.CAN-12-1645. https://pubmed.ncbi.nlm.nih.gov/23019224/
3. Daizumoto, Kei, Yoshimaru, Tetsuro, Matsushita, Yosuke, Kanayama, Hiro-Omi, Katagiri, Toyomasa. 2018. A DDX31/Mutant-p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer. In Cancer research, 78, 2233-2247. doi:10.1158/0008-5472.CAN-17-2528. https://pubmed.ncbi.nlm.nih.gov/29440146/
4. Jin, Yi, Wang, Zhanwang, Xiang, Kaimin, Cao, Ke, Jiang, Jiaode. 2022. Comprehensive development and validation of gene signature for predicting survival in patients with glioblastoma. In Frontiers in genetics, 13, 900911. doi:10.3389/fgene.2022.900911. https://pubmed.ncbi.nlm.nih.gov/36035145/
5. Ghafouri-Fard, Soudeh, Asadi, Mohammad, Sohrabi, Behnoush, Taheri, Mohammad, Samsami, Majid. 2021. Down-regulation of a panel of immune-related lncRNAs in breast cancer. In Pathology, research and practice, 224, 153534. doi:10.1016/j.prp.2021.153534. https://pubmed.ncbi.nlm.nih.gov/34175685/
智鼠故事 
